NASDAQ:SABS | Profit Breakdown | SAB Biotherapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$23.38M-$22.49M
2026-03-31-$20M-$18.87M
2025-12-31-$15.77M-$16.86M
2025-09-30-$12.68M$45.45M
2025-06-30-$9.73M-$10.11M
2025-03-31-$10.77M-$5.2M
2024-12-31$114,698.00-$10.01M-$11.39M
2024-09-30-$11.31M-$10.35M-$10.35M
2024-06-30$263,137.00-$10.2M-$7.34M-$7.34M
2024-03-31$944,575.00-$11.39M-$5.03M-$5.03M
2023-12-31$305,011.00-$18.87M-$22.86M-$22.86M
2023-09-30$1.27M-$5.32M-$5.1M-$5.1M
2023-06-30$85,518.00-$6.48M-$6.88M-$6.88M
2023-03-31$581,101.00-$7.4M-$7.35M-$7.35M
2022-12-31$2.16M-$7.86M-$7.85M-$7.87M
2022-09-30$3.59M-$7.81M-$7.08M-$7.08M
2022-06-30$6.35M-$6.54M-$4.87M-$4.78M
2022-03-31$11.8M-$6.71M$1.08M$985,863.00
2021-12-31$11.06M-$7.34M-$11.55M-$11.55M
2021-09-30$14.68M-$3.99M-$4.06M-$4.06M
2021-06-30$18.21M-$2.87M-$2.94M-$2.94M
2021-03-31$16.93M$813,924.00$1.41M$1.41M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$0.00-$48.95M$13.27M$13.27M
2024-12-31$1.32M-$42.91M-$34.11M
2023-12-31$2.24M-$38.08M-$42.19M-$42.19M
2022-12-31$23.9M-$28.92M-$18.72M-$18.74M
2021-12-31$60.88M-$13.39M-$17.14M-$17.14M
2020-12-31$55.24M$20.56M$20.12M$20.12M

Research interface only. Not investment advice. Prices are a checked-in snapshot, not live quotes.